INS and Hypoglycemia: Between two RCTs and one cohort study, rapid-acting insulin analogs significantly improved post-iftar blood glucose (20, 31) and overall blood glucose compared to regular human insulin without the risk of increased hypoglycemia (20, 22, 31).